Haemonetics stock near weekly lows as bullish momentum diverges from short-term selling pressure

Traders Union
All News
Companies
Haemonetics slides 1.55% today

Highlights

HAE is consolidating within a $71.00 to $77.00 range, currently trading toward the lower end amid ongoing selling pressure.
Technical structure remains broadly bullish in the medium to long term despite recent price weakness and oversold short-term oscillators.
Immediate support lies near $71.00 and $67.50, with a breakout above $76.00 opening potential for a move toward $78.00.

Bullish structure as price hovers near clustered support levels

HAE is currently trading at $73.02, which is above the MA-20 ($71.28) but well above both MA-50 ($63.38) and MA-200 ($63.81), suggesting a bullish long-term and medium-term structure with the price near short-term support. The Ichimoku Kijun on D1 is $67.58, so this level serves as immediate support. Near-term support is clustered at the MA-20 ($71.28) and the Ichimoku Kijun ($67.58), while key support is at MA-50 ($63.38). Immediate resistance is at MA-5 ($75.29), with key resistance at MA-10 ($76.00).

Divergent momentum signals as selling pressure anchors weekly lows

Momentum indicators offer a mixed picture. MACD and HMA on D1 indicate strong bullish momentum, supported by ADX, while Stoch RSI is in oversold territory and CCI remains neutral. BBP on D1 signals overbought conditions, showing buyer dominance despite the negative price action. RSI is above 60, which supports the bullish outlook, though several short-term oscillators are oversold, underlining the divergence between momentum and overbought signals. HAE has declined $1.15 (1.52%) over the past week, slipping from the previous weekly close of $74.17 to $73.02, and is currently at the very bottom of its weekly range. Weekly volatility stands at 8.85%. The week’s tone marks a steady decline from the high, with today’s session continuing that trend (down 1.55%), highlighting ongoing selling pressure.

Balanced risk as price consolidates near range support

For the coming week, an adjusted forecast range of $71.00 to $77.00 is appropriate, keeping well within typical volatility and placing the current price near the lower end of this band. The chance of a price increase is moderate, at 50%, based on the split between "Buy" and "Neutral" signals from RSI-W1, ADX-W1, MACD-W1, and MA-50-W1; a price decline is equally likely in the short term. The baseline scenario sees HAE consolidating between $71.00 and $77.00. A bullish move could push above resistance at $76.00, triggering a possible run towards $77.00–$78.00. A bearish scenario would see a breakdown below $71.00, potentially targeting the $67.50 zone. This expected range is closer to the mid-point between the 52-week low ($47.32) and high ($87.32), showing HAE remains well above its annual floor but off its highs.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Haemonetics had entered a period of heightened volatility with early signs of potential trend exhaustion following strong bullish momentum. As market conditions continue to evolve, investors should monitor for decisive directionality before positioning, as a clear breakout or reversal could define the next phase in HAE's performance.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.